Welcome

The first meeting of National Cancer Institute Directors took place at the European Institute of Oncology in Milan, Italy when five National Cancer Institute Directors enjoyed a two day meeting and Symposium. Since 2002, meetings have been extended to include Directors of Regional Cancer Institutes and have experienced a growing success with continually increasing participation.

Since inception attendees representing a wide range of countries including China, India, Brazil, Russian Federation, Singapore, Japan, Sri Lanka, Thailand, Korea, Peru, Brazil, Mexico, Colombia, Australia, France, United Kingdom, Sweden, New Zealand, Germany, Italy, Belgium, United States of America, Hungary, Poland, Switzerland, Nigeria, Senegal, Zimbabwe, Cameroon, Guinee, Turkey, Tanzania, Serbia, Tunisia, Algeria, Canada, Nepal, Bangladesh, Ireland, Pakistan and Sierra Leone have been in attendance.

The ninth meeting of National Cancer Institute Directors will take place in Lyon between 9th and 11th July, 2014 as decided last year. The previous meeting attracted 80 participants from 45 countries at varying levels of income and resource level. The 2014 meeting has already attracted a great deal of interest and several projects initiated at our last meeting have come to fruition and the results will be presented this year. As requested by participants, the focus on cancer care will continue to increase with the sharing of experience in a wide variety of resource settings highlighted. Highlights this year will include: plans for the follow-up of the successful ‘State of Oncology Report’; presentation of a planned programme regarding access to cancer drugs in lower-resource regions of the world; and update of the importance of nutrition in all aspects of cancer development and control; presentation of current status and issues in population screening in high-income and low-income countries; presentation of the Strathclyde Institute for Global Public Health at iPRI; and presentation of the Quinquennial Report of the International Prevention Research Institute.

Last year, the Alliance of Cancer Institute Directors was announced and this year it shall be formalised. Presentations at these meetings have underlined the great need for effective and sustainable partnerships to achieve practical cancer treatment and control. Many Institutes work in isolation and would benefit from a platform to share knowledge and ideas on the implementation of modern cancer treatments and prevention strategies. The development of an Alliance of Cancer Institute Directors would aim to help achieve these goals. The proposal now is to develop an Alliance around this Annual Meeting. Registration fees shall involve a one-time payment of a banknote valued at the lowest unit of local currency for an individual member¬ship and 10 units for an entire Institute. During the meeting, elements of a possible constitution shall be discussed and agreed.

The growing cancer burden worldwide presents major challenges for public health and healthcare delivery in all parts of the world. It needs also to be recognised that there are two types of individuals at the centre of this forthcoming epidemic: those patients with cancer and those at risk of developing the disease. Delivery of effective cancer care to patients in countries at all resource levels is of crucial importance. It is also critical to identify and implement effective cancer prevention strategies to contribute to reducing the cancer burden. A key message is that we must lose the silo mentality and consider prevention of all non-communicable diseases simultaneously.

On behalf of iPRI and the World Prevention Alliance, I would like to thank you for your participation in this meeting where your expertise will be invaluable in contributing to worldwide cancer prevention.

Peter Boyle

MEETING AGENDA

WEDNESDAY 9 JULY 2014 – MORNING

• 09:00 Introduction and Welcome; Peter Boyle

Session 1: Nutrition and Cancer – Chair: Aasim Yusuf

• 09:15 Nutrition and Cancer Risk; Patrick Mullie
• 09:45 Palliative Nutrition and Cancer; Pierre Singer
• 10:15 Malnutrition in Cancer: Why, What, When?; Dan L Waitzberg
• 10:45 Coffee Break

Session 2: Nutrition and Health – Chair: Luis Pinillos Ashton

• 11:15 Sugar, Cancer and Chronic Disease; Philippe Autier
• 11:45 Artificial Sweeteners; Dan Krewski
• 12:15 Physical Activity and Health; Robert Ross
• 12:45 Summary and Discussion
• 13:00 Lunch

WEDNESDAY 9 JULY 2014 – AFTERNOON

Session 3: Access – Chair: Peter Boyle

• 14:00 Global Disparities in Cancer; Otis Brawley
• 14:20 Impact of Access to Innovative Treatments Through a Public Private Partnership; Pat Garcia-Gonzalez
• 14:50 Policy Perspective and Needs; Richard Sullivan
• 15:00 Towards Affordable Cancer Care; Egbert Schilling
• 15:30 Group Picture and Coffee Break
• 16:00 Cancer Care: Patient’s Perspective; Jean Mossman
• 16:20 Patient’s Perspective: Disease Orientated; Markus Wattenberg
• 16:40 Pathways of Care; Robert Thomas
• 17:10 Targeted Therapy for Cancer: An Update; Gordon McVie
• 17:40 View from Uganda; Donato Greco
• 18:00 Close of Meeting

THURSDAY 10 JULY 2013 – MORNING

Session 4: Fifth Anniversary of iPRI – Chair: Murat Tuncer

• 09:00 Introduction; Peter Boyle
• 09:15 Cancer Screening; Philippe Autier, Mathieu Boniol
• 09:40 Diabetes and Cancer; Maria Bota, Alice Koechlin, Peter Boyle
• 10:05 Nutrition and Cancer; Patrick Mullie, Philippe Autier
• 10:30 Lifestyle, Environment and Cancer; Donato Greco, Cécile Pizot, Peter Boyle, Alice Koechlin, Chris Robertson
• 10:50 iPRI Quinquennial Report; Peter Boyle
• 11:00 Coffee Break

Session 5: Global Public Health – Chair: Harry Burns

• 11:30 Research on Nicotine and Tobacco:Why Bother?; Nigel Gray
• 12:00 Clean Drinking Water: Experience in Malawi; Robert Kalin
• 12:30 Post-conflict Public Health; Richard Sullivan
• 13:00 Lunch

THURSDAY 10 JULY 2014 – AFTERNOON

Session 6: Special Lectures – Chair: Otis Brawley

• 14:00 Basic Elements of Clinical Trials; Ian Ford
• 14:30 Quality Control in Molecular Cancer Diagnostics; Kurt Zatloukal
• 15:00 Cancer Medicines Policy: A UK Overview; Henry Burkitt
• 15:30 Coffee Break

Session 7: Special Lectures – Chair: Richard Sullivan

• 16:00 Biobanking in Europe BBMRI-ERIC; Markus Pasterk
• 16:30 International Standards for Biobanks; Jim Vaught
• 17:00 Austrian Drug Screening Institute; Gunther Bonn
• 17:30 World Innovation Summit for Health (WISH); Egbert Schilling
• 18:00 Close of Meeting
• 19:30 Bus departure for dinner
• 20:00 Dinner at Restaurant Fond Rose

FRIDAY 11 JULY 2014 – MORNING

Session 8: Cancer Around the World – Chair: Peter Boyle

• 09:00 Bangladesh; Syed Hussain
• 09:20 Indonesia; Rukmini Mangunkusumo
• 09:40 Nigeria; Clement Adebamowo
• 10:00 Pakistan; Aasim Yusuf
• 10:10 Vietnam; Nguyen Van Dinh
• 10:40 Mauritius; Nassera Chalabi
• 10:55 Mozambique; Otilia Soares
• 11:15 Coffee Break

Session 9: Special Lectures – Chair: Ed Trapido

• 11:30 Tackling Global Disparities; Harry Burns
• 12:00 People and Performance; Alistair Fraser
• 12:30 Experimental Surgery in 2014. Development of HIFU Treatment of Liver Metastases in Leon Berard Cancer Center; Michel Rivoire
• 13:00 Lunch

FRIDAY 11 JULY 2014 – AFTERNOON

Session 10: Special Lectures – Chair: Cemil Alyanak

• 14:00 Global Cancer Nursing; Annie Young
• 14:30 One hundred Years of Cancer Mortality in Scotland; Peter Boyle
• 15:00 Cancer in Latin America; Nise Yamaguchi
• 15:30 Conclusions and Coming Events; All
  • State of Oncology: New Projects; Peter Boyle
  • World Colorectal Cancer Report
  • World Bladder Cancer Report
  • EURAMA Breast Cancer Meeting in Oman; Adil Al-Ajmi
• 15:30 Close of Meeting